Novo Holdings A/S Q3 2023 significant ownership

Add to watchlist

Novo Holdings A/S is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Novo Holdings A/S Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%
Mirum Pharmaceuticals, Inc.August 18, 20221,760,0004.8%
Checkmate Pharmaceuticals, Inc.Sold outJune 03, 202200.0%
Nkarta, Inc.June 03, 20222,238,3094.6%
Morphic Holding, Inc.February 22, 20221,845,0304.9%
Exscientia plcFebruary 02, 202213,086,60011.0%
Aligos Therapeutics, Inc.January 31, 20221,950,0004.9%
Freeline Therapeutics Holdings plcNovember 02, 20211,785,5635.0%
Inogen IncSeptember 20, 20211,079,3204.7%
Inozyme Pharma, Inc.July 30, 20211,167,7065.0%
Harmony Biosciences Holdings, Inc.May 21, 20212,416,2544.2%
Praxis Precision Medicines, Inc.May 03, 20211,442,0803.7%
Verona Pharma plcFebruary 05, 202112,893,2503.1%
SeaSpine Holdings CorpDecember 30, 20201,346,4874.8%
Entasis Therapeutics Holdings Inc.August 11, 20201,173,8964.3%
Corvus Pharmaceuticals, Inc.July 09, 20201,389,4985.0%
Nabriva Therapeutics plcJuly 01, 20193,446,5644.7%
Akebia Therapeutics, Inc.January 07, 20193,100,000-
Menlo Therapeutics Inc.Sold outJanuary 07, 201900.0%
ORTHOPEDIATRICS CORPDecember 13, 2018654,5494.6%
Invuity, Inc.Sold outOctober 29, 201800.0%
Merus N.V.July 27, 20181,102,7954.9%
Ra Pharmaceuticals, Inc.March 02, 20181,531,5624.9%
REATA PHARMACEUTICALS INCSold outNovember 13, 201700.0%
KalVista Pharmaceuticals, Inc.Sold outOctober 13, 201700.0%
HTG MOLECULAR DIAGNOSTICS, INCAugust 29, 201749,7860.4%
Apollo Endosurgery, Inc.August 16, 2017671,8723.9%
ObsEva SAJuly 28, 2017916,4893.1%
iRhythm Technologies, Inc.Sold outMay 09, 201700.0%
CoLucid Pharmaceuticals, Inc.Sold outApril 20, 201700.0%
Invuity, Inc.February 08, 20171,318,4487.8%
Ophthotech Corp.Sold outDecember 19, 201600.0%
Tobira Therapeutics, Inc.August 10, 2016173,9050.9%
Tokai Pharmaceuticals IncFebruary 10, 2016470,9462.1%
Flexion Therapeutics IncSeptember 30, 20151,033,1314.8%
NEVRO CORPSeptember 14, 2015625,7042.2%
ALDER BIOPHARMACEUTICALS INCJuly 02, 20151,951,1834.6%
Otonomy, Inc.June 12, 2015875,0253.6%
BIOMIMETIC THERAPEUTICS, INC.December 03, 20124,720,06516.7%

Compare quarters

Export Novo Holdings A/S's holdings

CSVXLS